GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test
At DNA Labs UAE, we offer the GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test at a cost of AED 3200.0.
Test Details
The GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test is a type of genetic test that analyzes the GFM1 gene for mutations or variations associated with combined oxidative phosphorylation deficiency type 1. This rare genetic disorder is characterized by impaired energy production in the cells due to defects in the oxidative phosphorylation process.
The GFM1 gene provides instructions for making a protein called mitochondrial translation elongation factor G1 (EF-G1), which is involved in the synthesis of proteins within the mitochondria. The Next-Generation Sequencing (NGS) technology used in this genetic test allows for the simultaneous analysis of multiple genes, including the GFM1 gene, to identify any potential variations or mutations that may be causing the disorder.
This test can help in confirming a diagnosis, predicting disease progression, and guiding treatment options for individuals suspected to have combined oxidative phosphorylation deficiency type 1.
Test Components and Price
- Test Name: GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test
- Components: Blood or Extracted DNA or One drop Blood on FTA Card
- Price: 3200.0 AED
Report Delivery
The report for the GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test will be delivered within 3 to 4 weeks.
Test Method
The GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test is conducted using NGS technology.
Test Type
This genetic test falls under the category of Metabolic Disorders.
Referring Doctor
This test can be referred by a General Physician.
Test Department
The GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test is conducted in the Genetics department.
Pre-Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 NGS Genetic DNA Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with Combined Oxidative Phosphorylation Deficiency Type 1.
It is crucial to note that this genetic test should be performed and interpreted by a qualified healthcare professional or genetic counselor, as they can provide the necessary guidance and counseling regarding the implications of the test results and any further actions that may be required.
Test Name | GFM1 Gene Combined oxidative phosphorylation deficiency type 1 Genetic Test |
---|---|
Components | |
Price | 3200.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GFM1 Gene Combined oxidative phosphorylation deficiency type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 1 |
Test Details |
GFM1 gene combined oxidative phosphorylation deficiency type 1 NGS genetic test is a type of genetic test that analyzes the GFM1 gene for mutations or variations associated with combined oxidative phosphorylation deficiency type 1. Combined oxidative phosphorylation deficiency type 1 is a rare genetic disorder characterized by impaired energy production in the cells due to defects in the oxidative phosphorylation process. The GFM1 gene provides instructions for making a protein called mitochondrial translation elongation factor G1 (EF-G1), which is involved in the synthesis of proteins within the mitochondria. The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the simultaneous analysis of multiple genes, including the GFM1 gene, to identify any potential variations or mutations that may be causing the disorder. This test can help in confirming a diagnosis, predicting disease progression, and guiding treatment options for individuals suspected to have combined oxidative phosphorylation deficiency type 1. It is important to note that this genetic test should be performed and interpreted by a qualified healthcare professional or genetic counselor, as they can provide the necessary guidance and counseling regarding the implications of the test results and any further actions that may be required. |